{"id":6199,"date":"2015-07-09T12:12:50","date_gmt":"2015-07-09T12:12:50","guid":{"rendered":"\/?p=6199"},"modified":"2015-07-09T12:39:28","modified_gmt":"2015-07-09T12:39:28","slug":"pharmacyte-biotech-inc-otcmktspmcbs-pump-goes-bad-again","status":"publish","type":"post","link":"\/articles\/pharmacyte-biotech-inc-otcmktspmcbs-pump-goes-bad-again\/","title":{"rendered":"Pharmacyte Biotech Inc. (OTCMKTS:PMCB)’s Pump Goes Bad Again"},"content":{"rendered":"\n

Pharmacyte Biotech Inc. (OTCMKTS:PMCB<\/a>)’s slide was interrupted for an all too brief period of time, but now the ticker is glowing red again. <\/p>\n

Pumped-up OTC Markets tickers tend to crash horribly – that’s just how things happen on this exchange. The main difference between a successful pump and a dud, is that a “good” pump can manage to make the inevitable crash happen after an explosion of volatility.<\/p>\n

Since PMCB<\/a> seems to be the most heavily promoted ticker on the whole exchange, with over 160 promotions in the last six months, it shouldn’t come as much of a surprise to anyone that it has had its fill of both successful pumps and tragicomic promotional failures.<\/p>\n

Unfortunately for opportunists who still want to make money trading PMCB<\/a>, paid pumps lose their effect over time, and since PMCB<\/a> has been on the receiving end of promotions non-stop for months, at this point investors seem unmoved by PMCB<\/a> pumps – which is why the ticker kept searching for rock bottom.<\/p>\n

In the end, it was the announcement that PMCB<\/a> is to be featured in Discovery Channel’s “NewsWatch” that brought investors back this time around, but it was clear from the get-go that their interest in PMCB<\/a> would only last for as long as the news was hot. As soon as that moment passed, the hype dissipated and the magic was gone with it – and now the ticker is sliding back to the bottom of the charts once more.<\/p>\n

And, truth be told, with PMCB<\/a>‘s history and current state being what it is, there’s a good reason for the slide and a good chance that said slide will continue for the foreseeable future.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmacyte Biotech Inc. (OTCMKTS:PMCB)’s slide was interrupted for an all too brief period of time, but now the ticker is glowing red again. Pumped-up OTC Markets tickers tend to crash horribly – that’s just...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1635],"class_list":["post-6199","post","type-post","status-publish","format-standard","hentry","category-news","tag-pmcb"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=6199"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6199\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=6199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=6199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=6199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}